These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11224376)

  • 21. Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery.
    Griebel G; Moindrot N; Aliaga C; Simiand J; Soubrié P
    Neurosci Biobehav Rev; 2001 Dec; 25(7-8):619-26. PubMed ID: 11801287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Paradoxical" effects of morphine on antipredator defense reactions in wild and laboratory rats.
    Blanchard DC; Weatherspoon A; Shepherd J; Rodgers RJ; Weiss SM; Blanchard RJ
    Pharmacol Biochem Behav; 1991 Dec; 40(4):819-28. PubMed ID: 1816569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).
    Yang M; Farrokhi C; Vasconcellos A; Blanchard RJ; Blanchard DC
    Behav Brain Res; 2006 Jul; 171(1):1-8. PubMed ID: 16621042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lasting anxiogenic effects of feline predator stress in mice: sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience.
    Adamec R; Head D; Blundell J; Burton P; Berton O
    Physiol Behav; 2006 Jun; 88(1-2):12-29. PubMed ID: 16624347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cocaine potentiates defensive behaviors related to fear and anxiety.
    Blanchard DC; Blanchard RJ
    Neurosci Biobehav Rev; 1999 Nov; 23(7):981-91. PubMed ID: 10580312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of D-amphetamine on defensive behaviors related to fear and anxiety.
    Markham CM; Yang M; Blanchard RJ; Blanchard DC
    Pharmacol Biochem Behav; 2006 Apr; 83(4):490-9. PubMed ID: 16624396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
    Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic.
    Blanchard DC; Griebel G; Blanchard RJ
    Eur J Pharmacol; 2003 Feb; 463(1-3):97-116. PubMed ID: 12600704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine produces panic-like flight responses in mice in the mouse defense test battery.
    Blanchard RJ; Kaawaloa JN; Hebert MA; Blanchard DC
    Pharmacol Biochem Behav; 1999 Nov; 64(3):523-8. PubMed ID: 10548266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6,2'-Dihydroxyflavone, a subtype-selective partial inverse agonist of GABAA receptor benzodiazepine site.
    Wang F; Xu Z; Yuen CT; Chow CY; Lui YL; Tsang SY; Xue H
    Neuropharmacology; 2007 Sep; 53(4):574-82. PubMed ID: 17681556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orphanin FQ, a novel neuropeptide with anti-stress-like activity.
    Griebel G; Perrault G; Sanger DJ
    Brain Res; 1999 Jul; 836(1-2):221-4. PubMed ID: 10415424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-lasting memory abnormalities following exposure to the mouse defense test battery: An animal model of PTSD.
    Philbert J; Belzung C; Griebel G
    Physiol Behav; 2015 Jul; 146():67-72. PubMed ID: 26066724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and lasting effects of FG-7142 on defensive and approach-attack behavior in cats--implications for models of anxiety which use response suppression.
    Adamec RE
    J Psychopharmacol; 1991 Jan; 5(1):29-55. PubMed ID: 22282119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries.
    Blanchard RJ; Griebel G; Henrie JA; Blanchard DC
    Neurosci Biobehav Rev; 1997 Nov; 21(6):783-9. PubMed ID: 9415903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative stimulus properties of the benzodiazepine receptor partial agonist beta-carbolines abecarnil and ZK 95962: a comparison with chlordiazepoxide.
    Andrews JS; Stephens DN
    Behav Pharmacol; 1991 Jun; 2(3):171-185. PubMed ID: 11224061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ondansetron, gender and antipredator defensive behaviour.
    Shepherd JK; Rodgers RJ; Blanchard RJ; Magee LK; Blanchard DC
    J Psychopharmacol; 1993 Jan; 7(1 Suppl):72-81. PubMed ID: 22290373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests.
    Reis FL; Masson S; de Oliveira AR; Brandão ML
    Pharmacol Biochem Behav; 2004 Oct; 79(2):359-65. PubMed ID: 15501313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactions to threat and personality: psychometric differentiation of intensity and direction dimensions of human defensive behaviour.
    Perkins AM; Corr PJ
    Behav Brain Res; 2006 Apr; 169(1):21-8. PubMed ID: 16406105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt).
    Rowlett JK; Tornatzky W; Cook JM; Ma C; Miczek KA
    J Pharmacol Exp Ther; 2001 Apr; 297(1):247-53. PubMed ID: 11259551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.